Walleye Capital’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Walleye Capital’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-49,979	Closed	-$997K	–	4101
2022 Q3	$997K	Buy	+49,979	New	+$659K	0.02%	974
2021 Q1	–	Sell	-50,500	Closed	-$1.76K	–	1454
2020 Q4	$1.76K	Buy	+50,500	New	+$2.2M	0.12%	147

Walleye Capital's FMTX Position: Q4 2022 in Review

Walleye Capital sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 49,979 shares — an estimated $997K sold.

Walleye Capital first reported a position in FMTX in Q4 2020 and held it in 2 quarters. The position peaked at $997K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Walleye Capital reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Walleye Capital sold 49,979 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $997K.
Walleye Capital first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
Walleye Capital's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $997K in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.